ClinConnect ClinConnect Logo
Search / Trial NCT04794582

Prevention of Incisional Hernia After Renal Transplantation

Launched by FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL · Mar 9, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Incisional Hernia Kidney Transplantation

ClinConnect Summary

This clinical trial is studying whether using a special mesh to reinforce the closure of the surgical incision after a kidney transplant can help prevent a common complication called an incisional hernia. An incisional hernia occurs when tissue pushes through the abdominal wall at the site of the surgery, which can be uncomfortable and may require further treatment. The researchers will follow participants for two years after their transplant to see if this method reduces the number of people who develop hernias.

To be eligible for this trial, you must be planning to receive your first kidney transplant. Unfortunately, if you have had a kidney transplant before, you cannot participate. If you join the study, you will receive care as part of your transplant process, and you will be monitored to see how well the mesh reinforcement works in preventing incisional hernias. This trial is currently recruiting participants, and it is open to individuals aged 65 to 74, regardless of gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Candidate for first kidney transplant
  • Exclusion Criteria:
  • Patient receiving a second or successive renal transplant.

About Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal

The Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal is a leading research organization dedicated to advancing biomedical science and enhancing patient care through innovative clinical trials. Located in Madrid, Spain, the foundation collaborates closely with healthcare professionals and academic institutions to facilitate cutting-edge research initiatives. Its mission is to foster a multidisciplinary approach to medical research, focusing on translating scientific discoveries into effective therapeutic strategies. By prioritizing patient safety and ethical standards, the foundation aims to contribute significantly to the global body of medical knowledge and improve health outcomes.

Locations

Madrid, , Spain

Patients applied

0 patients applied

Trial Officials

VICTORIA GOMEZ

Principal Investigator

Fundación para la Investigación Biomédica del Hospital Unive

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials